CrushSCI.com
提供学术论文选刊润色服务
Blood Cancer Journal 期刊封面 医学
返回期刊列表

Review Cycle Records

Blood Cancer Journal

Springer SCIE OA
2026新锐 1区2025中科院 1区 TOP2025 JCR Q1
96.4平均天数
86中位天数
19最短天数
203最长天数
2272025发文量

Paper Review Records

全部论文审稿周期

17 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

107 天

Post-transplant hypomethylating agents plus venetoclax maintenance improves survival in high-risk myeloid malignancies: A matched cohort study

作者Haley Thigpen; Kendall Diebold; Todd Mudd; Maris Hardee; Manuel Espinoza-Gutarra; Antonio Di Stasi; Donna Salzman; Razan Mohty; Jorge Cortes; Ravi Bhatia; Omer Jamy

作者单位1. Department of Medicine, University of Alabama at Birmingham, Birmingham, USA; 2. Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, USA

PDF源文件 DOI 网页
19 天

Treatment of adult acute lymphoblastic leukemia—a therapeutic revolution in the making

作者Hagop Kantarjian; Ayalew Tefferi

作者单位1. Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, USA; 2. Mayo Clinics, Rochester, USA

PDF源文件 DOI 网页
203 天

Association between diabetic control and progression of monoclonal gammopathy of undetermined significance to multiple myeloma

作者Lawrence Liu; Byron Sigel; Mei Wang; Nikhil Grandhi; Martin W. Schoen; Kristen M. Sanfilippo; Kenneth R. Carson; Murali Janakiram; Tzeyu L. Michaud; Graham A. Colditz; Theodore S. Thomas; Su-Hsin Chang

作者单位1. Research Service, St. Louis Veterans Affairs Medical Center, St. Louis, USA; 2. Department of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, USA; 3. Department of Medicine, Washington University School of Medicine, St. Louis, USA; 4. Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, USA; 5. The University of Texas MD Anderson Cancer Center, Houston, USA; 6. Division of Hematology and Medical Oncology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, USA; 7. Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, USA; 8. Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, USA; 9. Department of Health Promotion, College of Public Health, University of Nebraska Medical Center, Omaha, USA

PDF源文件 DOI 网页
113 天

Venetoclax, azacitidine, and G-CSF targeting molecular residual disease in CBFB::MYH11 AML resistant to high-dose cytarabine

作者Ting Shi; Ruicong Xue; Jing Jia; Menghan Liu; Yalan Zhou; Chuanying Geng; Yuan Jian; Ying Tian; Yanru Zhang; Wenjing Li; Lefu Huang; Huixing Zhou; Aijun Liu; Wen Gao; Wenming Chen; Yun Leng; Yin Wu; Hong-Hu Zhu

作者单位1. Department of Hematology, Beijing Chao-Yang Hospital, Beijing, China; 2. Institute for Cancer, Chinese Institutes for Medical Research, Beijing, China; 3. Beijing Key Laboratory of Tumor Resistance Mechanism and Clinical Translation, Beijing, China

PDF源文件 DOI 网页
78 天

Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

作者Lei Ju; Sifeng Gao; JiLei Zhang; Yuyu Liu; Qiang Song; Lin Dong; Yan Guo; Xuemei Qin; Jie Zou; Chenglu Yuan; Yan Shi; Dexiao Kong; Kaifeng Wang; Qiang Li; Donglin Yang; Qingliang Teng; Erlie Jiang; Jun Peng; Guanchen Bai

作者单位1. Department of Hematology, The Affiliated Tai’an City Central Hospital of Qingdao University, Taian, China; 2. Department of Hematology, Qilu Hospital of Shandong University, Jinan, China; 3. Department of Hematology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China; 4. Department of Hematology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China; 5. Department of Hematology, The Qilu Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China; 6. Department of Hematology, People’s Hospital of Zhangqiu District, Jinan, China; 7. Department of Hematology, Liaocheng People’s Hospital, Liaocheng City, China; 8. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China; 9. State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Department of Hematology, Qilu Hospital of Shandong University, Jinan, China

PDF源文件 DOI 网页
65 天

Olverembatinib plus immunotherapy versus olverembatinib plus allogeneic hematopoietic cell transplantation in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

作者Chenying Li; Hongyan Tong; Huafeng Wang; Yanling Ren; Jiejing Qian; Xinping Zhou; Gaixiang Xu; Liangshun You; Liping Mao; Haitao Meng; Wenjuan Yu; Xingnong Ye; Min Yang; Jian Huang; De Zhou; Wanzhuo Xie; Jie Jin; Yinjun Lou

作者单位1. Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China; 2. Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, PR China; 3. Zhejiang Provincial Clinical Research Center For Hematological disorders, Hangzhou, PR China; 4. Zhejiang University Cancer Center, Hangzhou, PR China

PDF源文件 DOI 网页
119 天

Pre-transplant molecular international prognostic scoring system score reduction is not associated with improved outcomes in myelodysplastic syndromes

作者Masataka Sakashita; Junya Kanda; Keiichiro Hattori; Nobuhiro Hiramoto; Nobuhiro Kanemura; Senji Kasahara; Mitsumasa Watanabe; Satoshi Yoshihara; Michiko Ichii; Nobuo Sezaki; Masaaki Tsuji; Takeshi Maeda; Ko Sasaki; Toshiyuki Kitano; Yasuko Miyahara; Tadakazu Kondo; Mamiko Sakata-Yanagimoto; Akifumi Takaori-Kondo; Seishi Ogawa; Yasuhito Nannya

作者单位1. Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; 2. Department of Hematology, Kanazawa University Hospital, Kanazawa University, Ishikawa, Japan; 3. Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 4. Department of Hematology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan; 5. Department of Hematology, Kobe City Medical Center General Hospital, Hyogo, Japan; 6. Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan; 7. Department of Hematology, Gifu Municipal Hospital, Gifu, Japan; 8. Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan; 9. Department of Hematology, Hyogo Medical University Hospital, Hyogo, Japan; 10. Department of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan; 11. Department of Hematology, Chugoku Central Hospital, Hiroshima, Japan; 12. Department of Hematology and Immunology, Japanese Red Cross Otsu Hospital, Otsu, Japan; 13. Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan; 14. Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan; 15. Department of Hematology, Medical Research Institute Kitano Hospital, Osaka, Japan; 16. Department of Hematology, Kyoto City Hospital, Kyoto, Japan; 17. Department of Hematology, University of Tsukuba Hospital, Division of Advanced Hemato-Oncology, Tsukuba, Japan; 18. Transborder Medical Research Center, University of Tsukuba, Tsukuba, Japan; 19. Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan; 20. Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。